World's Best Scientists 2026 revealed!
Felice Giangaspero

Felice Giangaspero

D-Index & Metrics

Medicine

D-Index
83
Citations
24098
World Ranking
15658
National Ranking
612

Felice Giangaspero publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Felice Giangaspero sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 478 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Felice Giangaspero D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Felice Giangaspero sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Felice Giangaspero is affiliated with Sapienza University of Rome in Italy, contributing extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research spans a wide array of topics, focusing primarily on glioma diagnosis and treatment, neuroblastoma research and treatments, and the role of microRNA in disease regulation.

The scientist's work is notably concentrated in several subfields, including genetics, molecular biology, cancer research, neurology, and pulmonary and respiratory medicine. Giangaspero's publications address various aspects of cancer biology, especially in the context of central nervous system tumors.

Key topics covered in their research include:

  • Glioma Diagnosis and Treatment
  • Neuroblastoma Research and Treatments
  • MicroRNA in disease regulation
  • Chromatin Remodeling and Cancer
  • Cancer-related molecular mechanisms research
  • Epigenetics and DNA Methylation
  • Meningioma and schwannoma management

Their most frequent publication venues include:

  • Neuro-Oncology
  • Cancers
  • Nature Communications
  • Journal of Neuro-Oncology
  • Diagnostics

Frequent coauthors include Manila Antonelli, Francesca Gianno, Francesca Romana Buttarelli, Evelina Miele, and Angela Mastronuzzi, reflecting a collaborative research network focused on oncological and neurological conditions.

Giangaspero's recent scholarly output includes the following significant papers:

  • Modeling medulloblastoma in vivo and with human cerebellar organoids, 2020, Nature Communications
  • Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline, 2023, Neuro-Oncology
  • Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study, 2021, Neuro-Oncology
  • Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification, 2022, Pathologica
  • Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas, 2020, European Journal of Cancer

Best Publications

  • DNA methylation-based classification of central nervous system tumours

    David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt

  • New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

    Dominik Sturm;Dominik Sturm;Brent A. Orr;Umut H. Toprak;Volker Hovestadt

  • International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

    David N. Louis;Arie Perry;Peter Burger;David W. Ellison

  • Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme

    P. C. Burger;P. J. Dubois;S. C. Schold;K. R. Smith

  • HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology.

    Herbert Budka;Clayton A. Wiley;Paul Kleihues;Juan Artigas

  • Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas.

    Eugenio Pozzati;Nicola Acciarri;Francesco Tognetti;Federica Marliani

  • MicroRNA profiling in human medulloblastoma

    Elisabetta Ferretti;Enrico De Smaele;Agnese Po;Lucia Di Marcotullio

  • Survival and Prognostic Factors of Early Childhood Medulloblastoma: An International Meta-Analysis

    Stefan Rutkowski;Katja Von Hoff;Angela Emser;Isabella Zwiener

  • Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study

    Herm J Lamberink;Willem M Otte;Ingmar Blümcke;Kees P J Braun

  • The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants

    Kristian W. Pajtler;Kristian W. Pajtler;Stephen C. Mack;Stephen C. Mack;Vijay Ramaswamy;Christian A. Smith

  • Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation

    Consuelo Amantini;Michela Mosca;Michela Mosca;Massimo Nabissi;R. Lucciarini

  • Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression

    Martin Hasselblatt;Stefan Gesk;Florian Oyen;Sabrina Rossi

  • Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity

    Andrey Korshunov;Dominik Sturm;Dominik Sturm;Marina Ryzhova;Volker Hovestadt

  • Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.

    Piergiorgio Modena;Elena Lualdi;Federica Facchinetti;Joris Veltman

  • Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group.

    Giorgio Perilongo;Maura Massimino;Guido Sotti;Tiziana Belfontali

  • Medulloblastoma with extensive nodularity: a variant with favorable prognosis.

    Felice Giangaspero;Giorgio Perilongo;Maria Paola Fondelli;Massimo Brisigotti

  • RENKCTD11 is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma

    Lucia Di Marcotullio;Elisabetta Ferretti;Enrico De Smaele;Beatrice Argenti

  • Extraventricular Neoplasms with Neurocytoma Features: A Clinicopathological Study of 11 Cases

    Felice Giangaspero;Giovanna Cenacchi;Luisa Losi;Serenella Cerasoli

  • Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome.

    Johan M. Kros;Thierry Gorlia;Mathilde C. Kouwenhoven;Ping Pin Zheng

  • Large-cell medulloblastomas. A distinct variant with highly aggressive behavior.

    Felice Giangaspero;Luca Rigobello;Manuela Badiali;Massimo Loda

Frequent Co-Authors

Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Torsten Pietsch
Torsten Pietsch University of Bonn
Vincenzo Esposito
Vincenzo Esposito Sapienza University of Rome
Andrey Korshunov
Andrey Korshunov German Cancer Research Center
Elisabetta Ferretti
Elisabetta Ferretti Sapienza University of Rome
David Capper
David Capper Charité - University Medicine Berlin
Marcel Kool
Marcel Kool German Cancer Research Center
Andreas von Deimling
Andreas von Deimling Heidelberg University
Dominique Figarella-Branger
Dominique Figarella-Branger Aix-Marseille University
Peter C. Burger
Peter C. Burger Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens the door to a range of online degree options and diverse career pathways. For those interested in mental health, advancing your career through fastest pmhnp program options can qualify you to become a Psychiatric Mental Health Nurse Practitioner swiftly and efficiently.

If you are more inclined toward healthcare leadership, a health care administration degree online can help you launch or advance your management career in hospitals, clinics, or public health organizations. Many students prioritize affordability; exploring the cheapest master's in healthcare administration allows you to gain a respected credential while reducing financial burden.

For those aiming for the highest level of nursing practice, pursuing the cheapest dnp programs online can offer flexibility and affordability without sacrificing educational quality. These related online degrees bring new opportunities for students hoping to shape the future of healthcare while balancing cost, convenience, and career growth.

Best Scientists Citing Felice Giangaspero

Trending Scientists

Recently Published Articles